Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next For The $1 Trillion Drugmaker
Eli Lilly (NYSE:LLY) opened Wednesday’s session with a blowout second-quarter earnings report, sending shares sharply higher and cementing the drugmaker’s status as the only pharmaceutical company trading above a $1 trillion market cap. The biggest question today for Lilly is… This post appeared first on… Read More »Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next For The $1 Trillion Drugmaker









